share_log

Shattuck Labs | UPLOAD: Others

Shattuck Labs | UPLOAD:其他

美股sec公告 ·  01/30 13:25
Moomoo AI 已提取核心信息
Shattuck Labs, Inc., a biotechnology company, has been informed by the United States Securities and Exchange Commission (SEC) that its registration statement on Form S-3, filed on January 24, 2024, will not undergo review. The SEC's communication, dated January 30, 2024, was addressed to Dr. Taylor Schreiber, the Chief Executive Officer of Shattuck Labs. The SEC's letter referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Additionally, the SEC reminded the company and its management of their responsibility to ensure the accuracy and adequacy of their disclosures, regardless of the SEC's level of review or lack thereof. The SEC provided contact information for further inquiries, directing questions to Cindy Polynice.
Shattuck Labs, Inc., a biotechnology company, has been informed by the United States Securities and Exchange Commission (SEC) that its registration statement on Form S-3, filed on January 24, 2024, will not undergo review. The SEC's communication, dated January 30, 2024, was addressed to Dr. Taylor Schreiber, the Chief Executive Officer of Shattuck Labs. The SEC's letter referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Additionally, the SEC reminded the company and its management of their responsibility to ensure the accuracy and adequacy of their disclosures, regardless of the SEC's level of review or lack thereof. The SEC provided contact information for further inquiries, directing questions to Cindy Polynice.
美国证券交易委员会(SEC)已通知生物技术公司Shattuck Labs, Inc.,其于2024年1月24日提交的S-3表格的注册声明将不接受审查。美国证券交易委员会于2024年1月30日致函沙特克实验室首席执行官泰勒·施雷伯博士。美国证券交易委员会的信中引用了与加快注册程序的请求有关的第460和461条。此外,美国证券交易委员会提醒该公司及其管理层,无论美国证券交易委员会的审查水平如何,他们都有责任确保披露的准确性和充分性。美国证券交易委员会提供了进一步调查的联系信息,并将问题直接交给了辛迪·波利尼斯。
美国证券交易委员会(SEC)已通知生物技术公司Shattuck Labs, Inc.,其于2024年1月24日提交的S-3表格的注册声明将不接受审查。美国证券交易委员会于2024年1月30日致函沙特克实验室首席执行官泰勒·施雷伯博士。美国证券交易委员会的信中引用了与加快注册程序的请求有关的第460和461条。此外,美国证券交易委员会提醒该公司及其管理层,无论美国证券交易委员会的审查水平如何,他们都有责任确保披露的准确性和充分性。美国证券交易委员会提供了进一步调查的联系信息,并将问题直接交给了辛迪·波利尼斯。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息